Punctal occlusion in the management of chronic Stevens-Johnson syndrome

被引:48
作者
Kaido, M
Goto, E
Dogru, M
Tsubota, K
机构
[1] Tokyo Dent Coll, Dept Ophthalmol, Ichikawa, Chiba, Japan
[2] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan
关键词
D O I
10.1016/j.ophtha.2003.09.034
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the effect of lacrimal punctal occlusion in the management of the ocular surface disease in chronic Stevens-Johnson syndrome. Design: Retrospective noncomparative case series. Participants: Thirty-one eyes of 18 patients with chronic Stevens-Johnson syndrome seen at the Department of Ophthalmology of the Tokyo Dental College were studied. Intervention: Patients' lacrimal puncta were occluded by cauterization or with punctal plugs. Main Outcome Measures: The effect of lacrimal punctal occlusion was evaluated by changes in subjective symptoms, best-corrected visual acuity (VA), Schimer test, tear clearance test, and ocular surface double vital staining before and after punctal occlusion. Results: After lacrimal punctal occlusion, symptomatic improvement was observed in 19 eyes (61.3%). The mean logarithmic VA showed significant improvement from -0.64 +/- 0.87 to -0.52 +/- 0.86 (P<0.05). The Schirmer I test results before punctal occlusion yielded a mean score of 7.4 +/- 8.7 mm, which changed to 10.2 +/- 8.3 mm after punctal occlusion. The mean preocclusion and postocclusion tear clearance values were 7.5 +/- 6.6 times and 4.9 +/- 4.8 times, respectively. The Rose Bengal staining score decreased from 4.7 +/- 2.8 to 2.7 +/-2.2 points (P<0.05), and the fluorescein staining score decreased from 5.0 +/- 2.3 to 2.2 +/- 2.5 points (P<0.05), respectively. Conclusions: Concurrent improvements in subjective symptoms, vital staining scores, and VA point to the favorable effects of lacrimal punctal occlusion for the ocular surface health in chronic Stevens-Johnson syndrome. Ophthalmology 2004;111:895-900 (C) 2004 by the American Academy of Ophthalmology.
引用
收藏
页码:895 / 900
页数:6
相关论文
共 24 条
[11]  
OHASHI Y, 1989, INVEST OPHTH VIS SCI, V30, P1879
[12]   EPIDERMAL GROWTH-FACTOR AND CORNEAL WOUND-HEALING - A MULTICENTER STUDY [J].
PASTOR, JC ;
CALONGE, M .
CORNEA, 1992, 11 (04) :311-314
[13]  
PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476
[14]  
Solomon A, 2000, COMP OPHTHALMOL UPDA, V3, P165
[15]   Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease -: A dose-ranging, randomized trial [J].
Stevenson, D ;
Tauber, J ;
Reis, BL .
OPHTHALMOLOGY, 2000, 107 (05) :967-974
[16]   PRACTICAL DOUBLE VITAL STAINING FOR OCULAR SURFACE EVALUATION [J].
TODA, I ;
TSUBOTA, K .
CORNEA, 1993, 12 (04) :366-367
[17]   Treatment of dry eye by autologous serum application in Sjogren's syndrome [J].
Tsubota, K ;
Goto, E ;
Fujita, H ;
Ono, M ;
Inoue, H ;
Saito, I ;
Shimmura, S .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1999, 83 (04) :390-395
[18]   THE IMPORTANCE OF THE SCHIRMER TEST WITH NASAL STIMULATION [J].
TSUBOTA, K .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1991, 111 (01) :106-108
[19]  
TSUBOTA K, 1995, OPHTHALMOLOGY, V102, P1486
[20]   Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation [J].
Tsubota, K ;
Satake, Y ;
Kaido, M ;
Shinozaki, N ;
Shimmura, S ;
Bissen-Miyajima, H ;
Shimazaki, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (22) :1697-1703